Skip to main content
Home
  • About
    • Board of Directors
    • Our Staff
    • Annual Reports
    • Policies
    • Fellowship
    • Careers
  • Projects
    • Column 1
      • Animal Health & Veterinary Medicine
        • Antimicrobial Use in Food Animals
        • Cross-Sectoral Health Threats
        • Industry SWOT Analysis
      • Expanded Access
        • E-request App
        • Navigator
        • Resources for COVID-19
      • FDA Patient Listening Sessions
      • Food & Nutrition
        • About
        • Food Traceability
        • Healthy Rule Roundtables
        • Nutrition Facts Label
        • Produce Safety Stakeholder Dialogue
        • Retail Dietitian Toolkit
    • Column 2
      • Improving Access to FDA Information
        • Understanding FDA & FDA-Regulated Products
        • Improving Access to Publicly Available FDA Information
      • Research
        • About
        • IMEDS
          • IMEDS Inquiry
        • Post Market Research
        • RAISE
        • Real World Data
        • Regulatory Science Accelerator
      • Substance Use Disorders
  • News and Events
    • Innovations in Regulatory Science & Policy Awards
    • 2025 Annual Public Meeting
    • Events
    • News
    • Publications
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
      1. Board of Directors
      2. Our Staff
      3. Annual Reports
      4. Policies
      5. Fellowship
      6. Careers
  • Projects
      1. Column 1
        1. Animal Health & Veterinary Medicine
          1. Antimicrobial Use in Food Animals
          2. Cross-Sectoral Health Threats
          3. Industry SWOT Analysis
        2. Expanded Access
          1. E-request App
          2. Navigator
          3. Resources for COVID-19
        3. FDA Patient Listening Sessions
        4. Food & Nutrition
          1. About
          2. Food Traceability
          3. Healthy Rule Roundtables
          4. Nutrition Facts Label
          5. Produce Safety Stakeholder Dialogue
          6. Retail Dietitian Toolkit
      2. Column 2
        1. Improving Access to FDA Information
          1. Understanding FDA & FDA-Regulated Products
          2. Improving Access to Publicly Available FDA Information
        2. Research
          1. About
          2. IMEDS
          3. Post Market Research
          4. RAISE
          5. Real World Data
          6. Regulatory Science Accelerator
        3. Substance Use Disorders
  • News and Events
      1. Innovations in Regulatory Science & Policy Awards
      2. 2025 Annual Public Meeting
      3. Events
      4. News
      5. Publications
  • Expanded Access eRequest

Evaluation of COVID-19 Immune Barrier and Reinfection Risk

  • Read more about Evaluation of COVID-19 Immune Barrier and Reinfection Risk

Macrophage Regulation of Ozone-Induced Lung Inflammation

  • Read more about Macrophage Regulation of Ozone-Induced Lung Inflammation

Multi-Center Registry for ME/CFS

  • Read more about Multi-Center Registry for ME/CFS

Teletechnology-assisted Home-based Exercise Program for Severe COVID-19

  • Read more about Teletechnology-assisted Home-based Exercise Program for Severe COVID-19

Study of HS-10517 in Chinese Adult Participants

  • Read more about Study of HS-10517 in Chinese Adult Participants

Recrudescence of Eating Conduct Disorders and Covid-19

  • Read more about Recrudescence of Eating Conduct Disorders and Covid-19

Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.

  • Read more about Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.

A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection

  • Read more about A Retrospective Cohort Study for Main Postoperative Complications After SARS-CoV-2 Infection

V+PSF-M for Tobacco Cessation in HIV Care in India

  • Read more about V+PSF-M for Tobacco Cessation in HIV Care in India

Immunity to Infection in Healthy Participants and Participants With Cancer

  • Read more about Immunity to Infection in Healthy Participants and Participants With Cancer

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 47
  • Page 48
  • Page 49
  • Page 50
  • Current page 51
  • Page 52
  • Page 53
  • Page 54
  • Page 55
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
admin@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA